CS1, a controlled-release formulation of valproic acid, for the treatment of patients with pulmonary arterial hypertension: Rationale and design of a Phase 2 clinical trial.
控制釋放瓦爾普酸(valproic acid)的CS1,用於治療肺動脈高壓患者:第2期臨床試驗的原理和設計。
Pulm Circ 2024-01-05
Impact of exenatide on weight loss and eating behavior in adults with craniopharyngioma-related obesity: the CRANIOEXE randomized placebo-controlled trial.
克蘭尼奧島相關肥胖成人接受 exenatide 對體重減輕和進食行為的影響:CRANIOEXE 隨機安慰劑對照試驗。
Eur J Endocrinol 2024-04-01
Aldosterone synthase inhibitors: a potential revival for treatment of renal and cardiovascular diseases.
醛固酮合成酶抑制劑:治療腎臟和心血管疾病的潛在復甦。
J Clin Endocrinol Metab 2024-12-10
Optimal functioning of hypothalamic-pituitary-adrenal axis after cessation of prednisolone therapy: a cross-sectional study in children with nephrotic syndrome.
停用prednisolone治療後下丘腦-垂體-腎上腺軸的最佳功能:針對腎病綜合症兒童的橫斷面研究。
Pediatr Nephrol 2025-01-10
Semaglutide and laparoscopic sleeve gastrectomy in an adolescent with congenital adrenal hyperplasia due to 21-hydroxylase: a case report.
因21-hydroxylase引起的先天性腎上腺增生症青少年使用Semaglutide與腹腔鏡袖狀胃切除術的個案報告。
J Med Case Rep 2025-01-25